Representative before the EPO

Employment test 51 - 200 employees
Company dna reddie and grose llp
operating since 1907
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Neil Thornton has worked on the following 14 EPO patent applications which have been published in the last five years:

EP12705388

THERAPEUTIC AGENTS WITH IMPROVED FIBRINOGEN BINDING

IPC classification:
A61K 47/48, A61P 7/00
Agent:
Neil Thornton, Reddie & Grose LLP
Agent:
Adamson Jones
Status:
EXAMINATION IN PROGRESS
EP12196314

Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response

IPC classification:
A61K 31/337, A61K 38/00, A61K 38/17, A61K 39/395, A61P 35/00
Applicant:
Immutep SA
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP12196316

Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response

IPC classification:
A61K 31/337, A61K 38/00, A61K 38/17, A61P 35/00
Applicant:
Immutep SA
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP12196313

Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response

IPC classification:
A61K 31/337, A61K 31/7052, A61K 38/00, A61K 38/17, A61K 39/395, A61P 35/00
Applicant:
Immutep SA
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP12799829

ZEOLITIC CATALYTIC CONVERSION OF ALCOHOLS TO HYDROCARBONS

IPC classification:
B01J 29/46, B01J 29/48, C07C 1/20, C10G 3/00, C12P 7/06, C12P 7/08, C12P 7/10
Applicant:
UT-Battelle, LLC
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
EXAMINATION IN PROGRESS
EP12196310

Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response

IPC classification:
A61K 31/337, A61K 31/704, A61K 38/00, A61K 45/06
Applicant:
Immutep SA
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
EXAMINATION IN PROGRESS
EP14171566

Soluble analyte detection and amplification

IPC classification:
C12Q 1/68
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
PATENT GRANTED
EP12782393

ACTIVE MATERIALS FOR PREVENTION AND TREATMENT OF FOULED SURFACES

IPC classification:
A61L 27/44, A61L 27/54, A61L 29/12, A61L 29/16, A61L 31/16, B82Y 30/00
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13717812

METHODS FOR OBTAINING LIQUID FROM A SOLID PHASE

IPC classification:
C12N 15/10
Applicant:
Cambridge Enterprise Ltd.
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP13752486

HYDROTHERMALLY STABLE, LOW-TEMPERATURE NOX REDUCTION NH3-SCR CATALYST

IPC classification:
B01D 53/56, B01D 53/94, B01J 29/70, B01J 29/76, B01J 29/78
Applicant:
UT-Battelle, LLC
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP13851256

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
GRANT OF PATENT INTENDED
EP14761233

CATALYTIC CONVERSION OF ALCOHOLS TO HYDROCARBONS WITH LOW BENZENE CONTENT

IPC classification:
B01J 29/08, B01J 29/18, B01J 29/40, B01J 29/80, C07C 1/20, C07C 2/66, C10G 3/00, C10G 35/095
Applicant:
UT-Battelle, LLC
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
EXAMINATION REQUESTED
EP14711596

HIV VIRAL LOAD TESTING

IPC classification:
C12N 7/02, C12Q 1/70
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
EXAMINATION IN PROGRESS
EP14830806

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/282, A61K 31/47, A61K 38/16, A61P 35/00, C07K 14/705
Agent:
Neil Thornton, Reddie & Grose LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature